SK28898A3 - Benzoxazindione derivatives, process for their preparation and their use - Google Patents

Benzoxazindione derivatives, process for their preparation and their use Download PDF

Info

Publication number
SK28898A3
SK28898A3 SK288-98A SK28898A SK28898A3 SK 28898 A3 SK28898 A3 SK 28898A3 SK 28898 A SK28898 A SK 28898A SK 28898 A3 SK28898 A3 SK 28898A3
Authority
SK
Slovakia
Prior art keywords
formula
compounds
alkyl
methoxycarbonyloxy
dioxo
Prior art date
Application number
SK288-98A
Other languages
English (en)
Slovak (sk)
Inventor
Lothar Heinisch
Steffen Wittmann
Ute Mollmann
Rolf Reissbrodt
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SK28898A3 publication Critical patent/SK28898A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SK288-98A 1997-03-05 1998-03-04 Benzoxazindione derivatives, process for their preparation and their use SK28898A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
SK28898A3 true SK28898A3 (en) 1998-11-04

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
SK288-98A SK28898A3 (en) 1997-03-05 1998-03-04 Benzoxazindione derivatives, process for their preparation and their use

Country Status (30)

Country Link
US (1) US6013647A (hu)
EP (1) EP0863139B1 (hu)
JP (1) JPH10316666A (hu)
KR (1) KR19980079905A (hu)
CN (1) CN1075064C (hu)
AR (1) AR010125A1 (hu)
AT (1) ATE200080T1 (hu)
AU (1) AU737760B2 (hu)
BR (1) BR9802894A (hu)
CA (1) CA2230965A1 (hu)
CO (1) CO4950613A1 (hu)
CZ (1) CZ65098A3 (hu)
DE (2) DE19708846A1 (hu)
DK (1) DK0863139T3 (hu)
ES (1) ES2157617T3 (hu)
GR (1) GR3035834T3 (hu)
HK (1) HK1015763A1 (hu)
HU (1) HUP9800472A3 (hu)
IL (1) IL123535A (hu)
NO (1) NO310657B1 (hu)
NZ (1) NZ329883A (hu)
PE (1) PE71799A1 (hu)
PL (1) PL325142A1 (hu)
PT (1) PT863139E (hu)
RU (1) RU2184114C2 (hu)
SI (1) SI0863139T1 (hu)
SK (1) SK28898A3 (hu)
UA (1) UA45414C2 (hu)
UY (1) UY24915A1 (hu)
ZA (1) ZA981847B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
CN101180298B (zh) * 2005-05-25 2011-04-27 埃科特莱茵药品有限公司 抗生素衍生物
TWI603962B (zh) 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
DE59800568D1 (de) 2001-05-03
ZA981847B (en) 1998-09-08
US6013647A (en) 2000-01-11
DE19708846A1 (de) 1998-09-17
CN1195664A (zh) 1998-10-14
IL123535A (en) 2000-10-31
ES2157617T3 (es) 2001-08-16
HUP9800472A3 (en) 2000-09-28
AU737760B2 (en) 2001-08-30
PL325142A1 (en) 1998-09-14
HUP9800472A2 (hu) 1999-06-28
BR9802894A (pt) 2000-03-21
PT863139E (pt) 2001-07-31
KR19980079905A (ko) 1998-11-25
SI0863139T1 (en) 2001-06-30
CA2230965A1 (en) 1998-09-05
UY24915A1 (es) 2000-12-29
EP0863139A1 (de) 1998-09-09
UA45414C2 (uk) 2002-04-15
IL123535A0 (en) 1998-10-30
NZ329883A (en) 1999-04-29
EP0863139B1 (de) 2001-03-28
AR010125A1 (es) 2000-05-17
PE71799A1 (es) 1999-08-07
CZ65098A3 (cs) 1998-09-16
GR3035834T3 (en) 2001-08-31
AU5645598A (en) 1998-09-10
JPH10316666A (ja) 1998-12-02
ATE200080T1 (de) 2001-04-15
HU9800472D0 (en) 1998-04-28
DK0863139T3 (da) 2001-04-30
NO310657B1 (no) 2001-08-06
CO4950613A1 (es) 2000-09-01
CN1075064C (zh) 2001-11-21
RU2184114C2 (ru) 2002-06-27
NO980929L (no) 1998-09-07
NO980929D0 (no) 1998-03-04
HK1015763A1 (en) 1999-10-22

Similar Documents

Publication Publication Date Title
RU2730012C2 (ru) Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
US6114310A (en) Efflux pump inhibitors
RU2740190C2 (ru) Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
Wittmann et al. New synthetic siderophores and their β-lactam conjugates based on diamino acids and dipeptides
ES2323527T3 (es) Compuestos utiles en el tratamiento del carbunco y en la inhibicion del factor letal.
SK28898A3 (en) Benzoxazindione derivatives, process for their preparation and their use
US6380181B1 (en) Synthetic catechol derivatives, method for production and use thereof
Wittmann et al. Catecholates and mixed catecholate hydroxamates as artificial siderophores for mycobacteria
MXPA98001743A (en) New derivatives of benzoxacindiona, procedure for its preparation and its emp
DE19625524C2 (de) Neue synthetische Catechol-Antibiotika-Konjugate und diese enthaltende Arzneimittel
US7488755B2 (en) Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
DE10111161A1 (de) Neue Siderophoranaloga als 4- oder 6-zähnige Eisenchelatoren auf der Basis von Aminosäuren oder Peptiden, Verfahren zu ihrer Herstellung und ihre Anwendung
JPH0291099A (ja) １−デオキシムラミルペプチド誘導体